Baseline resistance-associated substitutions may impact DAA response among treatment failure chronic hepatitis C patients with pegylated interferon and ribavirin in real life.,Antiviral Therapy

当前位置： X-MOL 学术 › Antivir. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Baseline resistance-associated substitutions may impact DAA response among treatment failure chronic hepatitis C patients with pegylated interferon and ribavirin in real life.
Antiviral Therapy ( IF 1.3 ) Pub Date : 2020-09-16 , DOI: 10.3851/imp3369
Shan Ren ₁ , Feili Wei ₂ , Yi Jin ₁ , Junfeng Lu ₁ , Zhimin He ₁ , Lina Ma ₁ , Yanhong Zheng ₁ , Junli Wang ₁ , Xinyue Chen ₁

Affiliation

To evaluate the impact of baseline resistance-associated substitutions (RAS) on direct-acting antivirals (DAAs) treatment response among the pegylated interferon in combination with ribavirin (PR) failing patients in a real-life setting.

中文翻译：